share_log

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lin Patrick

SEC announcement ·  Apr 13 04:58
Summary by Futu AI
On January 1, 2024, Patrick Lin, Chief Business - Strategy Officer of Processa Pharmaceuticals, Inc. [PCSA], completed a stock transaction involving the company's common stock. Lin executed a sale of 539 shares at a price of $2.79 per share, resulting in a total transaction value of $1,503.81. This transaction was part of a disposal activity described as payment of exercise price or tax liability by delivering or withholding securities. Additionally, Lin acquired 1,675 shares through the exercise or conversion of derivative security, which did not have a reported transaction price. Following these transactions, Lin's direct holdings in Processa Pharmaceuticals common stock amounted to 28,614 shares.
On January 1, 2024, Patrick Lin, Chief Business - Strategy Officer of Processa Pharmaceuticals, Inc. [PCSA], completed a stock transaction involving the company's common stock. Lin executed a sale of 539 shares at a price of $2.79 per share, resulting in a total transaction value of $1,503.81. This transaction was part of a disposal activity described as payment of exercise price or tax liability by delivering or withholding securities. Additionally, Lin acquired 1,675 shares through the exercise or conversion of derivative security, which did not have a reported transaction price. Following these transactions, Lin's direct holdings in Processa Pharmaceuticals common stock amounted to 28,614 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.